Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.

Saved in:
Bibliographic Details
Title: Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.
Authors: Draeger KE; Glimepiride Multicentre Study Group, Hoechst AG, Frankfurt, Germany., Wernicke-Panten K, Lomp HJ, Schüler E, Rosskamp R
Source: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme [Horm Metab Res] 1996 Sep; Vol. 28 (9), pp. 419-25.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 0177722 Publication Model: Print Cited Medium: Print ISSN: 0018-5043 (Print) Linking ISSN: 00185043 NLM ISO Abbreviation: Horm Metab Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0018-5043
DOI:10.1055/s-2007-979830